by Tim Olmstead | Jan 25, 2022 | Uncategorized
Insights Our Blog Crista Parsons Spotlight Welcome Crista L. Parsons, CPhT, MBA We are excited to announce that Crista L. Parsons, CPhT, MBA has joined our team as a Consultant and Subject Matter Expert. Crista comes to Alinea Group with a strong healthcare...
by Tim Olmstead | Jan 12, 2022 | Uncategorized
Insights Our Blog Scott Patton Spotlight How long have you been a part of the Alinea-Group? I have been with Alinea for just under 2 years now. What brought you to the company? I have wanted to be a part of the company since I first interacted with them as a part of...
by Tim Olmstead | Dec 21, 2021 | Uncategorized
Insights Our Blog The Crossroads of 340B and Biosimilars: Challenges and Opportunities If you are a hospital or pharmacy provider, it’s no surprise that the growth of biologic drug spending (14.6%) was more than double the growth of overall drug spending (6.1%)...
by Tim Olmstead | Dec 3, 2021 | Uncategorized
Insights Our Blog Jamila Seibel Spotlight How long have you been a part of the Alinea-Group? I started with Alinea in 2015. What brought you to the company? I have known Shrujal Patel, one of the founding partners, since 1998 when I started pharmacy school. I like to...
by Russ Barron | Nov 22, 2021 | Uncategorized
Insights Our Blog 340B Compliance: Split Billing Software and Missing Data It’s 3:00 AM — Do you Know Where Your Data is Right Now? As experts in 340B compliance, we work through operational details and nuances that many times go unnoticed without a trained or...
by Russ Barron | Sep 28, 2021 | Uncategorized
Insights Our Blog Russ Barron Spotlight People are the core of our business at The Alinea Group. People on our team of experts, the people we serve as our clients, and the people we impact through our knowledge and promotion of the 340B Program. In the Alinea Group...
